Alexion Pharmaceuticals, Inc.
Overview
Alexion Pharmaceuticals, Inc., now a subsidiary of AstraZeneca, is a global biopharmaceutical company focused on serving patients and families affected by rare diseases through the development and delivery of innovative treatments. The company is particularly known for its work in research and development in the fields of hematology, nephrology, neurology, and metabolic disorders.
Core services & business areas
Therapeutic areas
FDA compliance signals
16 FDA enforcement records linked to this company.
- 4832025-03-07
Failure to comply with REMS Implementation System
- 4832024-11-07
Failure to review ADE information
- 4832024-11-07
Failure to develop written procedures
- 4832024-11-07
Late submission of an ICSR
- 4832024-11-07
Late submission of 15-day report
- 4832014-09-26
Late submission of 15-day report
- 4832014-09-26
Late submission of annual safety reports
- 4832014-08-22
Procedures for non-sterile drug products
- 4832014-08-22
Procedures not in writing, fully followed
- 4832014-08-22
Supervisor Training/Education/Experience
- recall — Class I2014-08-13
Presence of Particulate Matter: Product failed the appearance for the presence of visible particles under labeled storage condition.
- recall — Class I2014-02-05
Presence of Particulate Matter: Failed the appearance test for the presence of visible particles.
- warning_letter2013-03-22
FDA Warning Letter (drug product)
- 4832012-08-17
Complaint Handling Procedure
- 4832012-08-17
Training--operations, GMPs, written procedures
Is this Alexion Pharmaceuticals, Inc.? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.